Abbott Laboratories Stock price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:26 2024-03-18 pm EDT 5-day change 1st Jan Change
112.4 USD -2.64% Intraday chart for Abbott Laboratories -6.45% +2.15%
Sales 2024 * 41.98B Sales 2025 * 44.97B Capitalization 195B
Net income 2024 * 6B Net income 2025 * 6.94B EV / Sales 2024 * 4.71 x
Net Debt 2024 * 2.65B Net cash position 2025 * 2.18B EV / Sales 2025 * 4.29 x
P/E ratio 2024 *
32.6 x
P/E ratio 2025 *
28.2 x
Employees 114,000
Yield 2024 *
1.93%
Yield 2025 *
2.06%
Free-Float 86.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.64%
1 week-6.45%
Current month-5.23%
1 month-1.38%
3 months+4.05%
6 months+11.33%
Current year+2.15%
More quotes
1 week
112.26
Extreme 112.26
120.93
1 month
112.26
Extreme 112.26
121.64
Current year
109.29
Extreme 109.29
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-03-18 112.4 -2.64% 12,991,000
24-03-15 115.5 -2.83% 22,415,678
24-03-14 118.8 -1.09% 4,952,259
24-03-13 120.2 -0.50% 3,421,685
24-03-12 120.8 +0.47% 3,079,726

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (38%); - vascular devices (21%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (17.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (11.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (12.7%). Net sales are distributed geographically as follows: the United States (41.5%), Germany (5.4%), China (4.9%), Japan (4.4%), India (3.8%), Switzerland (3.1%), Canada (2.9%) and other (34%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
112.4 USD
Average target price
125.5 USD
Spread / Average Target
+11.59%
Consensus
  1. Stock
  2. Equities
  3. Stock Abbott Laboratories - Nyse